Please solve the following that are marked red. The answers are not currently in Chegg, I have checked.

Forecast Income Statement and Balance Sheet

Following are the income statement and balance sheet for Medtronic PLC.

Income statement

Net sales	$30,557
Costs and expenses
Cost of products sold	9,155
Research and development expense	885
Selling, general, and administrative expense	10,418
Amortization of intangible assets	1,764
Restructuring charges, net	75
Certain litigation charges, net	166
Other operating expense, net	258
Operating profit	7,836
Other nonoperating income, net	(142)
Interest expense	1,444
Income before income taxes	6,534
Income tax provision	547
Net income	5,987
Net income loss attributable to noncontrolling interests	(19)
Net income attributable to Medtronic	$5,968

Balance Sheet

Current assets
Cash and cash equivalents	$4,393
Investments	5,455
Accounts receivable, net	6,222
Inventories, net	3,753
Other current assets	815
Total current assets	20,638
Property, plant, and equipment, net	4,675
Goodwill	39,959
Other intangible assets, net	20,560
Tax assets	577
Other assets	1,014
Total assets	$87,423
Current liabilities
Current debt obligations	$838
Accounts payable	1,953
Accrued compensation	2,189
Accrued income taxes	567
Other accrued expenses	2,925
Total current liabilities	8,472
Long-term debt	24,486
Accrued compensation and retirement benefits	1,651
Accrued income taxes	2,838
Deferred tax liabilities	1,278
Other liabilities	288
Total liabilities	39,013
Shareholders equity
Ordinary shares	0
Additional paid-in capital	24,730
Retained earnings	26,270
Accumulated other comprehensive loss	(2,711)
Total shareholders equity	48,289
Noncontrolling interests	121
Total equity	48,410
Total liabilities and equity	$87,423

Assumptions

Investments		No change
Accounts receivable, less allowance	20.4%	of net sales
Inventories, net	12.3%	of net sales
Other current assets	7%	of net sales
Goodwill		No change
Tax assets	5%	of net sales
Other assets	3.3%	of net sales
Accounts payable	6.4%	of net sales
Accrued compensation (current liability)	7.2%	of net sales
Accrued compensation and retirement benefits (noncurrent liability)		No change
Accrued income taxes (current liability)	1.9%	of net sales
Other accrued expenses	9.6%	of net sales
Accrued income taxes (noncurrent liability)	9.3%	of net sales
Deferred tax liabilities	4.2%	of net sales
Other liabilities	2.5%	of net sales
Ordinary shares		No change
Accumulated other comprehensive loss		No change
Net income attributable to noncontrolling interest	$19	million
Dividends in FY2020	$2,853	million
CAPEX in FY2019	$1,134	$million, forecast CAPEX at historic % of net sales
Depreciation expense in FY2020	$950	million
Amortization expense in FY2020	$1,914	million
Debt due in FY2020	$838	million
Debt due in FY2021	$2,058	million

\begin{tabular}{|l|r|} \hline Accumulated other comprehensive loss & (2,711) \\ \hline Total shareholders' equity & 53,300 \\ \hline Noncontrolling interests & (121) \\ \hline Total equity & 53,421 \\ \hline Total liabilities and equity & $93,122 \\ \hline \end{tabular} \begin{tabular}{|l|r|} \hline Accumulated other comprehensive loss & (2,711) \\ \hline Total shareholders' equity & 53,300 \\ \hline Noncontrolling interests & (121) \\ \hline Total equity & 53,421 \\ \hline Total liabilities and equity & $93,122 \\ \hline \end{tabular}